僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Murlentamab （3C23K; GM102） is a humanized anti-AMHRII antibody. AMHRII is the anti-Müllerian hormone receptor. Murlentama significantly promotes macrophage-mediated antibody-dependent cell-mediated cytotoxicity （ADCC）. Murlentama stimulates pro-inflammatory and anti-tumor internal environment, recruits and activates T cells. Murlentama suppresses tumors growth by inducing na?ve macrophage orientation and promoting tumor-associated macrophage （TAM） reprogramming